(Reuters) -Humana Inc said on Thursday it would sell a 60% interest in its hospice business, Kindred at Home, for $2.8 billion to private investment firm Clayton, Dubilier & Rice, sending its shares up nearly 2% before the bell.

After purchasing the 60% remaining stake from TPG Capital, which was $5.7 billion in order to grow its patient care operations, the U.S. insurance company took complete ownership of Kindred at Home.

Humana (NYSE: ) announced that the company intends to repay debts and purchase shares with proceeds.

This transaction is not expected to have a significant impact on 2022 earnings. It will close during the third quarter 2022.

Kindred at Home offers more than hospice care. They also offer personal care and health services at home.

The deal will close and the Hospice and Personal Care divisions will be restructured to become an independent operation. David Causby, who is the President and CEO of the segments, will lead the company.

Goldman Sachs & Co (NYSE:). LLC Barclays Humana’s financial advisors are (LON:). Deutsche Bank (ETR:) Securities Inc and UBS Investment Bank are acting as financial advisers to CD&R.